期刊文献+

全反式维甲酸治疗低危组MDS的疗效观察

Observation on Efficacy of All-trans Retinoic Acid in the Treatment of Low-danger MDS
下载PDF
导出
摘要 目的:观察以全反式维甲酸为主的治疗方案治疗骨髓增生异常综合征(MDS)的临床效果。方法:2001年3月-2007年3月来我院治疗的低危组骨髓增生异常综合征患者68例,随机分为治疗组和对照组。对照组中的低危组给予叶酸、维生素B12和雄激素。治疗组在补充叶酸、维生素B12的治疗基础上加服全反式维甲酸。结果:治疗组的总有效率为75.61%,高于对照组的48.15%,两者之间有统计学意义(P<0.05)。结论:采用全反式维甲酸为主的治疗方案治疗低危组MDS的疗效较好,服用简单、毒副反应低,是一种有效的治疗方法。 Objective: To observe the effect of all--trans retinoic acid in the treatment of low--danger myelodysplastie syndrome (MDS). Methods:68 cases with low--danger MDS from Mar. 2001 to Mar. 2007 were randomly divided into treatment group and control group. The control group was given folic acid, vitamin B12 and androgen, while the treatment group was added all--trans retinoic acid on the oasis of folic acid and vitamin B12. Results: The total, effective rates were 75.61% in treatment group and 48.15% in control group, the difference had statistical significance (P〈0.05). Conclusions: All--trans retinoic acid is an effective method in the treatment of low--danger MDS which have good effect and low toxic side effect.
出处 《内蒙古中医药》 2008年第7期25-26,共2页 Inner Mongolia Journal of Traditional Chinese Medicine
关键词 全反式维甲酸 骨髓增生异常综合征 All--trans retinoie acid Myelodysplastie syndrome
  • 相关文献

参考文献7

二级参考文献24

  • 1[1]Folkman J. [J]. N Engl J Med, 1995, 333: 1757-1763. 被引量:1
  • 2[2]Shalaby F. [J]. Nature, 1995,376:62-66. 被引量:1
  • 3[3]Risau W. [J]. Circ Res, 1998,82:926-928. 被引量:1
  • 4[4]Lee WS. [J]. Circ Res, 1998,82:842-851. 被引量:1
  • 5[5]Rajkumar SV, Greipp PR. [J]. Hematol Oncol Clin North Am, 1999,13,1295-1314. 被引量:1
  • 6[6]Vacca A, Ribatti D, Roncall L, et al. [J]. Br J Hematol, 1994, 87:503-508. 被引量:1
  • 7[7]Antonio R, Atayde P, Stephen ES, et al. [J]. Am J Pathol, 1991,150:815-821. 被引量:1
  • 8[8]Hussong W, George MR, Paul JS. [ J]. Blood, 2000,95: 309-313. 被引量:1
  • 9[9]Pador T, Sandra R, Ralf B, et al. [J]. Blood ,2000, 95: 2637-2644. 被引量:1
  • 10[10]Willer A, Paul LR, Suanne S, et al. [J]. Blood,2000,96:748a. 被引量:1

共引文献66

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部